Stay updated on Parpvax: Niraparib + Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the Parpvax: Niraparib + Immunotherapy Clinical Trial page.

Latest updates to the Parpvax: Niraparib + Immunotherapy Clinical Trial page
- Check4 days agoChange DetectedThe page’s footer revision tag was bumped from v3.5.2 to v3.5.3, indicating a minor update to the ClinicalTrials.gov site version without changing the study content displayed.SummaryDifference0.1%

- Check11 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check40 days agoChange DetectedRevision v3.5.0 has been added, replacing the previous v3.4.3.SummaryDifference0.1%

- Check47 days agoChange DetectedRevision updated to v3.4.3, replacing the previous v3.4.2. This is a non-content update and does not affect study details or user-facing functionality.SummaryDifference0.1%

- Check76 days agoChange DetectedA new site revision banner shows Revision: v3.4.2, and the government funding status notice has been removed.SummaryDifference0.4%

- Check83 days agoChange DetectedAdded a site-wide lapse-in-funding notice about NIH Clinical Center operations with links to cc.nih.gov and opm.gov. Updated the page revision to v3.4.1, replacing the previous v3.4.0 revision.SummaryDifference0.4%

Stay in the know with updates to Parpvax: Niraparib + Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Parpvax: Niraparib + Immunotherapy Clinical Trial page.